Newsmeme!
Discover News you didn't know existed
Bostwick Therapeutics announced today that it has received clearance from the U.S. Food and Drug Administration and the Institutional Review Board of Community Memorial Hospital, Ventura, CA., to initiate the CRITICAL (CRyotherapy and IntraTumoral Immunotherapy with immature dendritic Cells (AutoLogous)) trial, a clinical trial examining the potential of a novel combination of cryoablation and ...
Bostwick Therapeutics announced today that it has received clearance from the U.S. Food and Drug Administration
Phase III pivotal study findings in the journal Vaccine showed that two formulations of CSL Biotherapies' influenza virus vaccine Afluria® elicited an immune response (also known as immunogenicity) in healthy adults aged 18 - About the Phase III Study The pivotal study was a National Institutes
Expression Genetics, Inc. announced today that the company's novel TheraPlas® cancer drug has been selected as one of the Top 10 most promising oncology products in development available for strategic partnering.
UroToday.com - Bladder cancer is an extremely lethal disease occurring in a large number of patients each year. Most evaluations that result in the diagnosis of bladder cancer are initiated with the finding of either gross or microscopic hematuria. While the majority of patients with hematuria will not have bladder cancer, a sizeable proportion will.
A recent study (doi:10.1016/j.clim.2008.06.009) published in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method enabling the detection of multiple parameters of single human cells.
Yassine Diboun will go 100 miles on foot to help a friend in need.
CSL Biotherapies, a subsidiary of one of the world's leading manufacturers of influenza vaccine, announced today that it has begun shipment of its influenza virus vaccine in the U.S. for the 2008-2009 season. CSL plans to deliver more than six million doses of Afluria and the majority of the supply will be in single-dose, thimerosal-free, pre-filled syringes.
CSL Biotherapies, a subsidiary of one of the world´s leading manufacturers of influenza vaccine,
KING OF PRUSSIA, Pa.----CSL Biotherapies, a subsidiary of one of the world's leading manufacturers of influenza vaccine, announced today that it has begun shipment of its influenza virus vaccine in the U.S. for the 2008-2009 season.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |